REMIGA

Serial Number 85357095
601

Registration Progress

Application Filed
Jun 27, 2011
Under Examination
Approved for Publication
Published for Opposition
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: REMIGA
Previous Owner: Glaxo Group Limited
Classes: 005

Trademark Image

REMIGA

Basic Information

Serial Number
85357095
Filing Date
June 27, 2011
Abandonment Date
November 23, 2011
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
601
Status Date
Nov 24, 2011
Classes
005

Rights Holder

Glaxo Group Limited

03
Address
Glaxo Wellcome House
Berkeley Avenue
Greenford, Middlesex UB60NN
GB

Ownership History

Glaxo Group Limited

Original Applicant
03
Greenford, Middlesex GB

Legal Representation

Attorney
Maribeth Day Case

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

9 events
Date Code Type Description Documents
Nov 25, 2011 MAB1 O ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT Loading...
Nov 24, 2011 ABN1 O ABANDONMENT - EXPRESS MAILED Loading...
Nov 23, 2011 EXAR I TEAS EXPRESS ABANDONMENT RECEIVED Loading...
Sep 30, 2011 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 30, 2011 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 30, 2011 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 29, 2011 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 2, 2011 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 30, 2011 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Translation
The word "REMIGA" has no meaning in a foreign language.

Classification

International Classes
005